Consumer Suit Challenging Zoloft’s Efficacy Untimely

A proposed consumer class suit alleging Zoloft maker Pfizer Inc. deceptively concealed the antidepressant’s ineffectiveness was time-barred, the U.S. District Court for the Northern District of California held Feb. 21 (Plumlee v. Pfizer Inc., 2014 BL 47071, N.D. Cal., No. 13-00414).

Plaintiff Laura A. Plumlee stopped purchasing Zoloft more than four years before she sued Pfizer under the California Unfair Competition Law (UCL), False Advertising Law and Consumers Legal Remedies Act. The UCL has a four-year limitations period; the other two laws have a three-year statute of limitations, the court said. At the latest, her last claim accrued ...